These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9871599)

  • 21. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.
    Fryer RM; Preusser LC; Calzadilla SV; Hu Y; Xu H; Marsh KC; Cox BF; Lin CT; Gopalakrishnan M; Reinhart GA
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):137-47. PubMed ID: 15243293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by protein kinase C of the 86Rb+ efflux and vasorelaxation induced by P1075, a K(ATP) channel opener, in rat isolated aorta.
    Linde C; Löffler C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):425-32. PubMed ID: 9303583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arylimino-1,2,4-thiadiazolidinones: a new family of potassium channel openers.
    Martínez A; Castro A; Cardelús I; Llenas J; Palacios JM
    Bioorg Med Chem; 1997 Jul; 5(7):1275-83. PubMed ID: 9377087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
    Perez-Medrano A; Buckner SA; Coghlan MJ; Gregg RJ; Gopalakrishnan M; Kort ME; Lynch JK; Scott VE; Sullivan JP; Whiteaker KL; Carroll WA
    Bioorg Med Chem Lett; 2004 Jan; 14(2):397-400. PubMed ID: 14698167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. K(ATP) channels mediate the beta(2)-adrenoceptor agonist-induced relaxation of rat detrusor muscle.
    Hudman D; Elliott RA; Norman RI
    Eur J Pharmacol; 2000 May; 397(1):169-76. PubMed ID: 10844111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do potassium channel openers compete with ATP to activate ATP sensitive potassium channels?
    Henry P; Escande D
    Cardiovasc Res; 1994 Jun; 28(6):754-9. PubMed ID: 7923275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic profiles of YM934, a novel potassium channel opener.
    Uchida W; Masuda N; Taguchi T; Shibasaki K; Shirai Y; Asano M; Matsumoto Y; Tsuzuki R; Fujikura T; Takenaka T
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):180-7. PubMed ID: 7511745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The electrophysiological effects of tetraphenylphosphonium on vascular smooth muscle.
    Zhang H; Bolton TB; Piekarska AE; McPherson GA
    Eur J Pharmacol; 1998 Apr; 347(1):119-23. PubMed ID: 9650857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.
    Manley PW; Löffler-Walz C; Russ U; Hambrock A; Moenius T; Quast U
    Br J Pharmacol; 2001 May; 133(2):275-85. PubMed ID: 11350864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potassium channel modulation in rat portal vein by ATP depletion: a comparison with the effects of levcromakalim (BRL 38227).
    Noack T; Edwards G; Deitmer P; Weston AH
    Br J Pharmacol; 1992 Dec; 107(4):945-55. PubMed ID: 1467843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects.
    Buchheit KH; Manley PW; Quast U; Russ U; Mazzoni L; Fozard JR
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):220-30. PubMed ID: 11882918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells.
    Gopalakrishnan M; Whiteaker KL; Molinari EJ; Davis-Taber R; Scott VE; Shieh CC; Buckner SA; Milicic I; Cain JC; Postl S; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 1999 Apr; 289(1):551-8. PubMed ID: 10087049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
    Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
    J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
    Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.
    Carroll WA; Altenbach RJ; Bai H; Brioni JD; Brune ME; Buckner SA; Cassidy C; Chen Y; Coghlan MJ; Daza AV; Drizin I; Fey TA; Fitzgerald M; Gopalakrishnan M; Gregg RJ; Henry RF; Holladay MW; King LL; Kort ME; Kym PR; Milicic I; Tang R; Turner SC; Whiteaker KL; Yi L; Zhang H; Sullivan JP
    J Med Chem; 2004 Jun; 47(12):3163-79. PubMed ID: 15163196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanosine diphosphate activates an adenosine 5'-triphosphate-sensitive K+ channel in the rabbit portal vein.
    Kajioka S; Kitamura K; Kuriyama H
    J Physiol; 1991 Dec; 444():397-418. PubMed ID: 1822556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.